TP53 and small cell lung carcinoma: Genetic-engineered mouse models have demonstrated that the loss of Rb1 and p53 induces SCLC,141 while the mutation in KrasG12D and p53 loss in AT2 cells could generate LUAD model in both mouse and human iPSC-derived lung organoids.142